Search Results
Search results for "Crinetics Pharmaceuticals"
Results found for "Crinetics Pharmaceuticals"
- Scott Struthers | Dr. GPCR Ecosystem
Prior to Crinetics, he was senior director and head of endocrinology and metabolism at Neurocrine Biosciences Struthers co-founded and serves as board chair at Radionetics Oncology, a pharmaceutical company focused Scott Struthers on the web LinkedIn Google Scholar Crinetics Radionetics Dr.
- Dr. Evi Kostenis | Dr. GPCR Ecosystem
Evi Kostenis "Pharmacist by training - PhD in Pharmacology - Postdoc at the NIH with Dr. Pharmacology at 7TM Pharma in Denmark; Full professor, department chair and director of the institute for pharmaceutical
- Dr. Khaled Abdelrahman | Dr. GPCR Ecosystem
Khaled Abdelrahman graduated in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University He is also a Registered Pharmacist in Canada and held two of the most prestigious Clinician Postdoctoral
- Dr. GPCR Team | Dr. GPCR Ecosystem
GPCR About John Azietaku John Teye Azietaku,PhD is a trained pharmacist, holding a Ph.D. in Drug Discovery committed to leveraging his expertise to enhance healthcare outcomes and contribute to the growth of the pharmaceutical GPCR About Cam Sinh Lu Cam Sinh Lu is a PhD student at Monash Institute of Pharmaceutical Sciences, Monash
- Dr. Khaled Abdelrahman, Victoria Rasmussen and Madelyn Moore | Dr. GPCR Ecosystem
Khaled Abdelrahman graduated in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University He is also a Registered Pharmacist in Canada and held two of the most prestigious Clinician Postdoctoral
- Eleonora Comeo: Fluorescent Ligands and the Pharmacology of Adenosine Receptors | Dr. GPCR Ecosystem
Eleonora Comeo, PhD candidate at the University of Nottingham and the Monash Institute of Pharmaceutical Comeo is a PhD candidate jointly enrolled at the University of Nottingham and the Monash Institute of Pharmaceutical A trained medicinal chemist and pharmacist, her research focuses on the design and synthesis of fluorescent
- Brian Arey - Part 2: GPCR Drug Discovery and the Science Nobody Publishes | Dr. GPCR Ecosystem
(s) Brian Arey - Part 2: GPCR Drug Discovery and the Science Nobody Publishes Drug discovery in the pharmaceutical In this conversation, Arey traces the full arc of how a pharmaceutical research program is born, resourced About the Guest Brian Arey is a pharmacologist and physiologist with over 25 years of pharmaceutical Arey calls this one of the most important and least instinctive skills in pharmaceutical research - and He then moved to work in the pharmaceutical industry where he has held positions of increasing responsibility
- Leadership, Impact, and GPCR Signaling with Dr. Michelle Halls | Dr. GPCR Ecosystem
How an integrated training and lab structure at Monash Institute of Pharmaceutical Sciences fosters innovation Professor at Monash University and Deputy Theme Leader of Drug Discovery Biology at Monash Institute of Pharmaceutical More about Michelle Halls Monash Institute of Pharmaceutical Sciences Bluesky LinkedIn Articles about
- A Brief History of allosteric modulation with Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
Christopoulos is the Professor of Analytical Pharmacology and the Dean of the Faculty of Pharmacy & Pharmaceutical In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr. Pharmaceutical Industry Experiences and GPCR History Arthur shared his experiences in the pharmaceutical
- Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
Christopoulos is the Professor of Analytical Pharmacology and the Dean of the Faculty of Pharmacy & Pharmaceutical In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr. Lastly, they discussed the growth and development of the Monash Institute of Pharmaceutical Sciences, They also discussed the disruption within the pharmaceutical sector, the importance of workforce development
- Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
Christopoulos is the Professor of Analytical Pharmacology and the Dean of the Faculty of Pharmacy & Pharmaceutical In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr. Lastly, they discussed the growth and development of the Monash Institute of Pharmaceutical Sciences, They also discussed the disruption within the pharmaceutical sector, the importance of workforce development
- Sam Hoare: Receptor Residence Time and GPCR Data Analysis | Dr. GPCR Ecosystem
Hoare now consults for biotech and pharmaceutical clients on GPCR data analysis, receptor binding kinetics data analyst and the founder of Pharmechanics LLC , a consultancy and data analysis company supporting pharmaceutical Hoare was a pharmacology leader in the pharmaceutical industry for 15 years at Neurocrine Biosciences
- Brian Arey: Discovering Signaling Bias at the FSH Receptor | Dr. GPCR Ecosystem
Florida State University before postdoctoral research at Northwestern, and has spent over 25 years in pharmaceutical classes The physiologist's approach to mechanistic drug discovery The erosion of pharmacology training in pharmaceutical He then moved to work in the pharmaceutical industry where he has held positions of increasing responsibility
- Celtarys Research | Dr. GPCR Ecosystem
Maria Majellaro earned her degree in Pharmaceutical Chemistry and Technology from the University of Bari Ligands in GPCR Research GPCRs are one of the most important families of therapeutic targets in the pharmaceutical
- Dr. Christel Menet | Dr. GPCR Ecosystem
I then started my career at Evotec before moving to Domain Therapeutics (called Faust pharmaceutical
- Dr. Graham Ladds | Dr. GPCR Ecosystem
These investigations have enabled him to foster strong collaborations with the pharmaceutical industry
- Dr. Hannes Schihada | Dr. GPCR Ecosystem
By the end of 2021, I moved back to Germany and joined the pharmaceutical chemistry group of Peter Kolb
- Smells Like GPCR Spirit: Cracking Olfactory Codes with Alessandro Nicoli | Dr. GPCR Ecosystem
.” – Alessandro Nicoli He studied pharmaceutical chemistry in Padua, where his fascination with molecular He obtained an MSc degree in Chemistry and Pharmaceutical Technology from the University of Padua (Italy
- Dr. Stephane Angers | Dr. GPCR Ecosystem
Angers established his independent research program in the Department of Pharmaceutical Sciences at the
- Dr. Nariman Balenga | Dr. GPCR Ecosystem
In 2021, I joined the Ferring Research Institute of Ferring Pharmaceuticals in San Diego as a scientist
- Chris Langmead | Dr. GPCR Ecosystem
and Better Medicines Theme Leader of the Neuromedicines Discovery Centre at the Monash Institute of Pharmaceutical
- Dr. Jean Martin Beaulieu | Dr. GPCR Ecosystem
of D2R signaling and explores the potential usefulness of beta-arrestins for the development of new pharmaceutical
- David Gloriam: Orphan Receptors, GPCRDB, and the Data Revolution in GPCR Pharmacology | Dr. GPCR Ecosystem
Welcome and introduction of David Gloriam 02:23 Career origins - from childhood medicine ambitions to pharmaceutical University of Copenhagen where he leads a research cluster for GPCR function and drug discovery and a Pharmaceutical
- Elva Zhao: G Protein Regulation and Biased Signaling at the GLP-1 Receptor | Dr. GPCR Ecosystem
About the Guest Elva Zhao is a Research Fellow at the Monash Institute of Pharmaceutical Sciences (MIPS About this episode Elva is currently a research fellow at the Monash Institute of Pharmaceutical Sciences
- How Lipid Rafts Organize GPCR Signaling | Dr. GPCR Ecosystem
contributing as a professor, senior lecturer, editorial board member, and scientific officer in both pharmaceutical
- Annette Gilchrist: Native Cell Systems, Biased Agonism, and the Pharmacogenomics Gap | Dr. GPCR Ecosystem
ABOUT THE GUEST Annette Gilchrist is Associate Professor of Pharmaceutical Sciences at Midwestern University Gilchrist is also an associate professor at the Department of Pharmaceutical Sciences.
- GPCR Pharmacology, Career Twists & Serendipity with Sokhom Pin | Dr. GPCR Ecosystem
Sokhom Pin Sokhom Pin is a receptor pharmacologist with over 20 years of drug discovery research in the pharmaceutical
- Anita Nivedha: Computational Dynamics of Ligand Bias in GPCR Signaling | Dr. GPCR Ecosystem
— Academic–industry collaborations in GPCR drug discovery Insights from collaborative research with pharmaceutical It also showed me how important GPCR research is in pharmaceutical development.
- GPCRs and the Science Behind Pain and Recovery with Dr. Alex Serafini | Dr. GPCR Ecosystem
Other academic interests of his include studying pharmaceutical finance & healthcare administration and
- When to Walk, When to Run: Lessons from the GPCR Trenches with Dr. Ben Clements | Dr. GPCR Ecosystem
He received his Ph.D. in Pharmaceutics from the University of Minnesota in 2022, studying the pharmacokinetics






























